The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.
Not Applicable
Completed
- Conditions
- Heart Rate VariabilityAnxietyBlood PressureEye Movement Desensitization and Reprocessing Intervention
- Interventions
- Behavioral: Eye Movement Desensitization and Reprocessing
- Registration Number
- NCT05836181
- Lead Sponsor
- Miao-Yi Chen
- Brief Summary
Eye Movement Desensitization and Reprocessing intervention may improve anxiety, depression, systolic blood pressure and heart rate variability in patients with hypertension.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
- age of 20-80 years,
- diagnosed with primary hypertension as in SBP ≥130 mmHg or DBP ≥80 mmHg,
- and able to read and understand Chinese or Taiwanese and willing to participate in this study,
Exclusion Criteria
- . Secondary hypertension
- . Hypertension Crisis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Eye Movement Desensitization and Reprocessing intervention Eye Movement Desensitization and Reprocessing The goal of EMDR is to help manage physical and mental unpleasant experiences due to hypertension. The intervention group received EMDR therapy included eight phases, each lasting 60-90 minutes, and the intervention consisted of four weekly. In this study, a Nurse practitioner trained in EMDR performs an intervention in an outpatient clinic's quiet, empty room.
- Primary Outcome Measures
Name Time Method Anxiety Six month HADS-A score
depression symptoms Six month CESD Scale
- Secondary Outcome Measures
Name Time Method Blood pressure Six month Blood pressure
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does EMDR therapy modulate autonomic nervous system activity to improve heart rate variability in primary hypertension patients?
What is the comparative effectiveness of EMDR intervention versus standard antihypertensive medications like ACE inhibitors in reducing systolic blood pressure and anxiety symptoms?
What biomarkers correlate with EMDR efficacy in reducing anxiety and blood pressure in NCT05836181 hypertension patients?
What are the potential adverse events associated with EMDR therapy in hypertension patients, and how do they compare to those of pharmacological treatments like beta-blockers?
How does combining EMDR with pharmacological agents like beta-blockers or SSRIs affect blood pressure control and mental health outcomes in primary hypertension?
Trial Locations
- Locations (1)
Chen, miao-yi
🇨🇳Taipei, Neihu, Taiwan